Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1684-1691

  Mathew, Anuja ^a   Kurane, Ichiro ^a   Rothman, Alan L ^a   Zeng, Ling Ling ^b   Brinton, Margo A ^b   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

cytotoxic T lymphocyte; dengue virus; epitope analysis; flavivirus

Indexed keywords

CD8 ANTIGEN; VIRUS ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; VACCINATION;

EID: 0029794031     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118964     Document Type: Article

References (28)

1. Halstead, S.B. 1988. Pathogenesis of dengue. Challenges to molecular biology. Science (Wash. DC). 239:476-481.
2. Halstead, S.B. 1988. Immunological parameters of togavirus disease syndromes. In The Togaviruses: Biology, Structure, Replication. R.W. Schlesinger, editor. Academic Press, New York. 107-173.
3. + CD8 cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65:1823-1828.
4. + T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis and precursor frequency determination. J. Virol. 67:5962-5967.
5. + cytotoxic T lymphocytes generated in short term culture. Viral Immunol. 6:143-151.
6. + cytotoxic T lymphocyte (CTL) clones: recognition of NS3 amino acids 500-508 by CTL clones of two different specificities. J. Immunol. 154:1287-1295.
7. + human cytotoxic T lymphocyte clones of heterogenous serotype specificities. J. Exp. Med. 182:853-863.
8. Kurane, I., D. Hebblewaite, W.E. Brandt, and F.A. Ennis. 1984. Lysis of dengue virus infected cells by natural cell mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J. Virol. 52:223-230.
9. Falgout, B., R. Chanock, and C.J. Lai. 1989. Proper processing of dengue virus nonstructural protein NS1 requires N terminal Hydrophobic signal sequence and the downstream nonstructural protein NS2a. J. Virol. 63:1852-1860.
10. Zhao, B., G. Prince, R. Horswood, K. Eckels, R.M. Chanock, and C.J. Lai. 1989. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. J. Virol. 64:4109.
11. + T-cell clones. J. Virol. 70: 3108-3117.
12. Bhamarapravati, N., S. Yoksan, T. Chayaniyayothin, S. Angsubphakorn, and A. Bunyaratvej. 1987. Immunization with a live attenuated dengue 2 virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bull. WHO. 65:189-195.
13. + cytotoxic T-lymphocyte clones. J. Virol. 70:141-147.
14. Innis, B.L. K.H. Eckels, E. Kraiselbard, D.R. Dubois, G.F. Meadors, D.J. Gubler, D.S. Burke, and W.H. Bancroft. 1988. Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J. Infect. Dis. 158:876-880.
15. Hoke, C.J., Jr., F.H. Malinozki, K.H. Eckels, S.R. McNair, D.R. Dubois, P.L. Summers, T. Simms, J. Burrows, S.E. Hasty, and W.H. Bancroft. 1990. Preparation of attenuated dengue 4 (341750 Carib.) virus vaccine. II. Safety and immunogenicity in humans. Am. J. Trop. Med. Hyg. 43:219-226.
16. Kurane, I., B.L. Innis, A. Nislak, C. Hoke, S. Nimmannitya, A. Meager, and F.A. Ennis. 1989. Human T cell responses to dengue virus antigens: proliferative responses and production. J. Clin. Invest. 83:506-513.
17. Dharakul, T., I. Kurane, N. Bhamarapravati, S. Yoksan, D. Vaughn, C.H. Hoke, and F.A. Ennis. 1994. Dengue virus specific memory T cell responses in human volunteers receiving a live attentuated dengue virus type 2 candidate vaccine. J. Infect. Dis. 170:27-33.
18. + human cytotoxic T lymphocytes. J. Virol. 63:5086-5091.
19. Rothman, A.L., I. Kurane, C.J. Lai, M. Bray, B. Falgout, R. Men, and F.A. Ennis. 1993. Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes. J. Virol. 67:801-806.
20. Kurane, I., A. Meager, and F.A. Ennis. 1989. Dengue virus specific human T cell clones: serotype cross-reactive proliferation, interferon production, and cytotoxic activity. J. Exp. Med. 170:763-775.
21. Kurane, I., and F.A. Ennis. 1992. Immunity and immunopathology in dengue virus infections. Semin. Immunol. 4:121-127.
22. Kurane, I., B.L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, J. Janus, and F.A. Ennis. 1991. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-γ in sera of children with dengue. J. Clin. Invest. 88: 1473-1480.
23. Kurane, I., and B.J. Mady. 1991. Antibody dependent enhancement of dengue virus infection. Rev. Med. Virol. 1:211-221.
24. DiBrino, M., K. Parker, D. Margulies, J. Shiloach, R. Turner, W. Biddison, and J. Coligan. 1995. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the caucasian population. Biochemistry. 34:10130-10138.
25. Barber, L.D., and P. Parham. 1994. The essence of epitopes. J. Exp. Med. 180:1191-1194.
26. Elliot, T., M. Smith, P. Driscoll, and A. McMichael. 1993. Peptide selection by class I molecules of the major histocompatibility complex. Curr. Biol. 3: 854-866.
27. Chiewslip, P., R. Scott, and N. Bhamarapravati. 1981. Histocompatibility antigens and dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 30:1101-1105.
28. McKee, K.T., Jr., W.H. Bancroft, K.H. Eckels, R.R. Redfield, P.L. Summers, and P.K. Russel. 1987. Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am. J Trop. Med. Hyg. 36:435-442.